Core Viewpoint - The health industry has become a new engine for economic development under the "Healthy China 2030" strategy, with Lishan Health Group emerging as a leader in the medical and health sectors since its establishment in January 2017 [1][2]. Strategic Layout - Lishan Health Group quickly recognized the potential of the health industry and aligned its development direction with national strategies, focusing on medical care, elderly care, and biomedicine [2]. Biomedicine - The company plays a significant role in the cell and gene therapy industry chain in Jinan, establishing a biomedicine industrial cluster in Lixia District, which includes the Lishan International Cell Medicine Industrial Park and the Lishan International Biopharmaceutical Production Base [3][6]. - The three core parks work synergistically to create a comprehensive industrial chain, providing full-stage services from research and development to large-scale production [6][7]. - Lishan Health emphasizes technological innovation and has established the first CDMO pilot base for immune cell and gene therapy in Shandong Province, focusing on advanced core technologies [7]. Health and Elderly Care - In the health and elderly care sector, Lishan Health promotes socialized and industrialized health services, with projects like the Lishan International Jinchen Elderly Care Center, which offers high-quality integrated medical and elderly care services [8][10]. - The Jinchen Elderly Care Center features a comprehensive service system for elderly care, including a partnership with a top-tier hospital to ensure seamless medical services [10]. - The Lishan International Jinchen Luoyuan project combines medical and elderly care, providing a high-quality care environment in a familiar setting for the elderly [11]. Company Growth and Recognition - Lishan Health has grown into an integrated industrial operation platform with over 3.6 billion in total assets and has received multiple awards and recognitions for its contributions to the health sector [14]. - The company aims to continue enhancing its service quality and expanding its service areas while focusing on innovation and collaboration with research institutions to advance cutting-edge technologies [14].

（原标题：估值超万亿，药食同源大戏开场） 虽然入局者变多，但业内普遍认为药食同源仍然是一个大有发展空间的蓝海。"相较于功能声称管控严格的保健品，药食同源物质兼具食品与中药 材属性，按普通食品管理具有显著便利性。同时，许多中药材的功效已深入人心。"中国工程院院士金征宇认为这是决定药食同源产业会有很大发 展的重要因素。 本质上来说，这些传统中药材之所以能够变为食品原料，就是因为市场看重了它们被科学验证或广泛认知的功效价值。从这个角度来看，药食同 源覆盖领域广泛，可以满足抗衰老、抗疲劳、降糖降脂、护肤美容等多个细分市场的需求。 国家统计局数据显示，2023年末，我国60岁以上人口达到2.96亿，老年人口基数大，且增长速度快。金征宇院士指出老年食品是药食同源的重要 部分，老年人对中药材功能认知更深，可针对性开发补气血、健脾胃、调节三高等功能的老年食品。 2025中国特种食品产业大会现场 当传统中药材开始"跨界"日常食品，一个万亿级产业正在加速破圈。 随着"健康中国"等利好政策的深入实施，以及全民健康意识的觉醒，药食同源产业迎来了爆发式增长。2025中国特种食品产业大会公布的数据显 示，我国药食同源市场规模已突破370 ...

近日，由中国医院协会主办的"2025中国医院大会暨行风建设大会"在京召开，以"向新・向质・向未来，开创高质量发展新局面"为主题，紧紧围绕国家卫生 健康委工作部署，助力医院高质量发展和行风建设。 国家卫生健康委员会党组副书记、副主任曾益新正在讲话 国家卫生健康委员会党组副书记、副主任曾益新说，医院要发挥好科技创新对卫生健康事业高质量发展的关键支撑作用，要营造风清气正的科研环境，重视 推进科技成果的转化和推广应用。医院要重视教书育人，落实领导责任制，把教育的职能摆在重要位置。公立医院作为守护人民健康的主阵地，必须勇担使 命，落实好新时期党的卫生健康工作方针。要加强党的领导，发挥好党组织的作用，特别是要发挥好基层党支部的作用，起到政治监督、政治保障、把握方 向的作用，使公立医院真正发挥好主力军的作用，做守护人民健康的忠诚卫士。 中国医院协会会长表示，随着健康中国战略的实施和医改的进一步深化，医疗机构不仅要提高自身医疗服务的质量和水平，加强学科建设和人才培养，加强 对基层医疗卫生服务的指导支持，有意识地提升医疗卫生服务体系的整体效率，促进形成分级诊疗和医防结合的有效机制；同时要进一步加强管理，进一步 强化人文关怀，为 ...

据悉，第八届进博会将于2025年11月5日至10日在国家会展中心（上海）举办，继续由国家综合 展、企业商业展、虹桥国际经济论坛、配套活动和人文交流活动等组成。企业商业展设立医疗器械及医 药保健（健康中国，美好生活）、汽车及智慧出行（出行，无限可能）、技术装备（创新与可持续未 来）、消费品（更高品质，更好生活）、农食产品（从全球农场到中国餐桌）、服务贸易（数字、互 联、绿色）六大展区及创新孵化专区（在中国，切入新赛道），将进一步创新展览题材，丰富展览内 容，更加聚焦全球领先的新产品、新技术、新服务，加大力度挖掘关键核心技术和产品。同时，还将继 续举办贸易投资对接会、重要采购商选品会、采购商"长廊"等展期活动，多维度打造展客商双向对接平 台，促进展客商深度交流与合作。 参展方面，国家综合展招展工作已全面启动，广泛邀请有意愿的国家和国际组织参展，展示综合形 象、贸易投资机遇、特色产业和优势产品等。企业商业展方面，已有来自70多个国家近800家企业签 约，展览面积近25万平方米。首批300余家参展商名单正式公布，其中，超100家展商为自首届进博会举 办以来连续8届参展的"全勤生"，充分体现各方对中国经济和进博会的信心 ...

长江商报消息 编 者 按 2024年，湖北大健康产业历史性突破万亿规模，成为全国生物医药版图的重要一极。 当前，湖北正以创新链重塑产业链，其发展路径不仅为中部地区树立标杆，更彰显了健康中国战略的地 方实践智慧。 站在万亿新起点，荆楚大地将继续以科技创新为笔，绘就大健康产业的全球坐标。长江商报推出本次专 题策划，挖掘湖北大健康产业背后的突破基因和未来蓝图。 实现跨越背后，是相关企业的快速发展。近年来，湖北强化主体实力，提升产业增长支撑力，着力引培 龙头企业，引进联影医疗、迈瑞医疗等龙头企业在武汉设立第二总部基地，人福医药等入选中国医药工 业百强；不断壮大上市公司，完善专精特新中小企业梯度培育机制，健全"选种、育苗、培优"全周期培 育体系。 报告显示，湖北规上生物医药企业达644家，实现利润总额148.4亿元。全省生物医药上市企业24家，数 量居全国第7。在抗病毒、激素类、儿童药等细分赛道处于国内领先地位。打造国家级制造业单项冠军6 个，培育国家级专精特新"小巨人"企业34家、省级专精特新"小巨人"企业257家，形成带动医药工业稳 定增长的主力军。 为突破性发展大健康产业，奋力抢占科技创新制高点，湖北还集中力量加 ...

Core Viewpoint - Shangde Life Health Industry Group aims to become a leading enterprise in health management services for high-income families globally, driven by the "Healthy China" and "Beautiful China" strategies [1][9]. Group 1: Achievements and Leadership - Shangde Life has made significant achievements in both domestic and international markets, with its chairman representing Chinese health brands at the Belt and Road Entrepreneurs Forum in 2023 [3]. - The group’s general manager participated in the 9th Doctor Cloud Conference, discussing the future of smart health with industry experts, highlighting its leadership position in the health sector [3]. Group 2: Research and Innovation - In 2024, the group plans to invest over 100 million USD to establish an international medical research laboratory focused on cutting-edge medical technology [6]. - The company is actively collaborating internationally, building 18 facilities, including a comprehensive stem cell building and research information center in countries like Tajikistan and Russia [6]. - Shangde Life enhances its core competitiveness in medical technology through the exclusive development of products like dihydroquercetin [6]. Group 3: Product Development - The group’s main brands reflect the traditional Chinese medicine concept of "food and medicine from the same source," utilizing modern extraction technologies to create effective health products [7]. - By integrating Western medical testing methods with traditional Chinese health principles, the company offers personalized health management services [7]. Group 4: Corporate Mission and Values - Shangde Life's mission is to "inherit traditional Chinese medicine and benefit human health," emphasizing values of integrity, responsibility, innovation, and win-win cooperation [8]. - The company aims to transform societal health concepts, providing professional and scientific health management services to a broader audience [8]. Group 5: Future Outlook - Looking ahead, Shangde Life intends to establish a global health management service center, leveraging its research capabilities, brand influence, and market advantages [9]. - The company will continue to deepen its commitment to traditional Chinese medicine and innovate products and services to enhance the health and happiness of its consumers [9].

厨房作为家庭生活的核心场景，长期存在一个被忽视的"隐形污染源"——厨房油烟。研究表明，厨房油烟的危害不亚于二手烟，长期暴露可能诱发呼吸 系统疾病、心血管问题甚至肺癌风险。 前不久，方太和苏宁易购在南京新街口联合发起了"游烟停"公益快闪行动，让公众直观感知厨房油烟的隐形危害。现场通过巨风挑战赛等可视化实验， 展现方太油烟机在极端风阻下的高效排烟性能，推动公众对厨房排烟认知升级。 随着《健康中国行动（2019-2030年）》深入推进，家庭健康场景成为战略落地的重要维度，而厨电产业正以技术创新回应这一需求，推动"厨房经 济"从功能消费向健康科技升级。 以三重突围构建厨电产业创新范式 工信部《智慧家庭综合标准化体系建设指南（2024 版）》将包括烹饪场景在内的智慧家务纳入八大应用场景，为行业发展提供了清晰指引。以技术创 新回应中式厨房健康需求，成为产业升级的重要方向。 这种创新范式的精髓在于扎根中国家庭。方太通过组建专业调研团队，深入全国调研，开展上千次模拟实验，建立中式烹饪油烟扩散数据库，自主研发 近吸、智能、低吸等多种烟机形态，打造适合中国家庭的"不跑烟"油烟机。 这种创新范式的关键在于掌握核心技术。据国家知识产 ...

以下文章来源于体重管理三年行动 ，作者体重管理三年行动 体重管理三年行动 . 响应国家"健康中国2030"战略，落实"体重管理年"三年行动，本账号发布权威资讯 前不久的两会上提出了"全民减肥"的倡议，随后官方发布公告，宣布2025年为"体重管理年"。这绝非小题大做，国家亲自推动体重管理，其背 后究竟有何深层原因？今天就和大家一起探讨，这场"健康大棋"背后的深远意义。 ▍当肥胖成为"资本陷阱" 去过美国的人可能都发现，超市里总是摆满了高糖高油的廉价食品，麦当劳等快餐店更是经常能看到身材肥胖的顾客。 ▍个人破局之道 作为一名运动营养师，我亲眼见证了许多学员的蜕变之路。究竟怎样科学减肥？请牢记"三维管理法"——饮食创新、运动规划、睡眠优化。 1. 饮食方面： 早餐建议优选高质量蛋白配合复合碳水； 午餐遵循"442法则"（4份蔬菜+4份蛋白+2份粗粮）； 晚餐以低碳水高蛋白为主。 另 外，每天要确保摄入2升水，有助于提升身体代谢。 2. 运动方面： 每日至少运动30分钟。 燃脂训练组合：开合跳和高抬腿间隔交替，确保心率维持在120-140。 塑形训练重点：壶铃训练针对臀 部、腿部和核心，哑铃主要锻炼胸部、肩部和背部， ...

以下文章来源于体重管理三年行动 ，作者体重管理三年行动 体重管理三年行动 . 响应国家"健康中国2030"战略，落实"体重管理年"三年行动，本账号发布权威资讯 | 主站首页 首页 | 最新信息 政策文件 关于我们 专题专栏 | | | --- | --- | --- | | 通告公告 | | ♀ 您现在所在位置: 首页 > 最新信息 > 综合管理 > 通告公告 | 到2030年，体重管理支持环境将得到广泛建设，全民体重管理的意识和能力明显增强，健康生活方式进一步普及，形成全民参与、人人受益的 良好体重管理氛围，超重肥胖人群增长势头初步遏制，部分人群的体重异常状况得到有效改善。 体重水平与人体健康息息相关，尤其是超重和肥胖，已成为引发心脑血管疾病、糖尿病及部分癌症等慢性疾病的主要风险因素。根据《中国居民营养与 慢性病状况报告（2020年）》的数据，我国18岁及以上成年人中，超重率达到34.3%，肥胖率为16.4%；6—17岁儿童青少年群体中，超重率为11.1%，肥 胖率为7.9%。整体来看，超重和肥胖问题形势严峻，迫切需要加强干预措施，积极加以改善。 ▍行动目标 ▍个人和家庭 2. 发挥专业技术优势，规范体重管 ...

Core Insights - The event showcased the launch of new products and strategic initiatives for the second half of 2025, including the first ESG report and a public welfare project [1][5][10] - The company emphasizes its commitment to sustainable development and health management, aligning with China's "Healthy China 2030" strategy [3][10] Group 1: Company Strategy and Vision - The chairman expressed the vision of the company as a sustainable enterprise, focusing on long-term growth and health management services [3] - The company aims to cultivate talent in chronic disease management and innovate products that integrate traditional Chinese medicine with modern technology [10][11] Group 2: ESG and Social Responsibility - The release of the first ESG report marks a significant step in the company's sustainable development efforts, establishing a benchmark in the industry [5][6] - The company has donated over 170 million yuan and has implemented projects that have reached 2 million families, aligning with China's dual carbon strategy [6] Group 3: Product Innovation - Four major new products were launched, including health drinks and high-end skincare products, which combine traditional wisdom with modern biotechnology [11][13] - The company has invested heavily in R&D, ensuring quality and innovation in its product offerings, with a focus on meeting national health needs [13] Group 4: AI and Digital Transformation - The company is embracing AI technology to reshape the health industry ecosystem, launching the "Chain Business 3.0" initiative for digital transformation [15] - The focus is on creating a collaborative ecosystem for distributors, enhancing operational efficiency through AI integration [15] Group 5: Community Engagement and Health Promotion - The "Herbal Station" project aims to promote community health through various services, including AI consultations and health education [8][10] - The company is committed to enhancing public health and contributing to the "Healthy China" initiative through innovative practices [8][10]